Keywords
Miomatose
Sangramento uterino anormal
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To analyze the characteristics of Adenomyosis and Uterine Myomatosis. Bibliographic Review: Abnormal uterine bleeding are common gynecological complaints in gynecology clinics, and may be caused by Uterine Adenomyosis or Uterine Myomatosis. These diseases can affect women of all ages, and are increasingly diagnosed in young women. Both pathologies are difficult to diagnose because their symptoms are very similar to other diseases, however, they can also be a differential diagnosis of each other. Symptoms such as hypermenorrhea, infertility, pain and anemia are common to be found in these disorders, affecting women's quality of life physically and emotionally. Final considerations: Uterine myomatosis and adenomyosis have numerous etiologies that have not yet been well disseminated, in addition, it is necessary to seek a quick, effective and conclusive diagnosis to perform the appropriate treatment to improve the lives of women who suffer from these diseases. The rapid identification of the disease and treatment has the benefit of avoiding traumas, medications and unnecessary surgical procedures that occur when there is no correct diagnosis.
References
ABBOTT JA. Adenomyosis and Abnormal Uterine Bleeding - Pathogenesis, diagnosis, and management. Best Pract Res Clin Obstet Gynaecol., 2017; 40: 68-81.
BENETTI-PINTO CL, et al. Abnormal Uterine Bleeding. Revista Brasileira de Ginecologia e Obstetrícia [online], 2017; 39(07): 358-368.
BENETTI-PINTO CL, et al. Pharmacological Treatment for Symptomatic Adenomyosis: A Systematic Review. Rev Bras Ginecol Obstet., 2019; 41(9): 564-574.
BOSTWICK DG, et al. Prostatic stromal proliferations: a review. Pathology, 2021; 53(1): 12-25.
BUGGIO L, et al. Adenomyosis: Impact on Fertility and Obstetric Outcomes. Reprod Sci., 2021; 28(11): 3081-3084.
BULUN SE, et al. Adenomyosis pathogenesis: insights from next-generation sequencing. Hum Reprod Update, 2021; 27(6): 1086-1097.
CÂMARA, F, et al. Principais causas ginecológicas de dor pélvica aguda em mulheres. Revista Feminina, 2021; 49(2): 115-120.
CHAPRON C, et al. Diagnosing adenomyosis: an integrated clinical and imaging approach. Hum Reprod Update, 2020; 26(3): 392-411.
CONWAY F, et al. Ulipristal acetate therapy increases ultrasound features of adenomyosis: a good treatment given in an erroneous diagnosis of uterine fibroids. Gynecol Endocrinol., 2019; 35(3): 207-210.
CUNNINGHAM RK, et al. Adenomyosis: A Sonographic Diagnosis. Radiographics, 2018; 38(5): 1576-1589.
DASON ES, et al. Diagnosis and treatment of adenomyosis. CMAJ, 2021; 193(7): E242.
FILHO A, et al. Evaluation of KI-67 expression in uterine leiomyoma and in healthy myometrium: a pilot stud. Rev. Assoc. Med. Bras, 2019; 65(12).
GIULIANI E, et al. Epidemiology and management of uterine fibroids. Int J Gynaecol Obstet., 2020; 149(1): 3-9.
HABIBA M, et al. Classifying Adenomyosis: Progress and Challenges. Int J Environ Res Public Health, 2021; 18(23): 12386.
ISLAM MS, et al. Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics. Hum Reprod Update, 2018; 24(1): 59-85.
LACHETA J, et al. Uterine adenomyosis: pathogenesis, diagnostics, symptomatology and treatment. Ceska Gynekol., 2019; 84(3): 240-246.
LEWIS TD, et al. A Comprehensive Review of the Pharmacologic Management of Uterine Leiomyoma. Biomed Res Int., 2018: 2414609.
MAIA CP, et al. Sangramento uterino anormal e o impacto na qualidade de vida de mulheres atendidas em unidade especializada do Amazonas. Revista Eletrônica Acervo Saúde, 2021; 13(5): e7364.
MOAWAD G, et al. Adenomyosis and infertility. J Assist Reprod Genet. 2022; 39(5): 1027-1031.
MUNRO MG. Uterine polyps, adenomyosis, leiomyomas, and endometrial receptivity. Fertil Steril. 2019; 111(4): 629-640.
OLIVEIRA MAP, et al. Surgery in adenomyosis. Arch Gynecol Obstet., 2018; n297(3): 581-589.
OLIVEIRA E, et al. The use of surgical hysteroscopy as an auxiliary method in the diagnosis of adenomyosis. Is it possible? Research, Society and Development, 2022; 11(10): e164111032369.
O'SHEA A, et al. Imaging Diagnosis of Adenomyosis. Semin Reprod Med., 2020; 38(2-03): 119-128.
PAVONE D, et al. Epidemiology and Risk Factors of Uterine Fibroids. Best Pract Res Clin Obstet Gynaecol.,
; 46: 3-11.
EL SABEH M, Saha SK, Afrin S, Islam MS, Borahay MA. Wnt/β-catenin signaling pathway in uterine leiomyoma: role in tumor biology and targeting opportunities. Mol Cell Biochem., 2021; 476(9): 3513-3536.
SHARARA FI, et al. Current and Prospective Treatment of Adenomyosis. J Clin Med., 2021;10(15): 3410.
UPSON K, et al. Epidemiology of Adenomyosis. Semin Reprod Med., 2020; 38(2-03): 89-107.
VAN DEN BOSCH T, et al. Ultrasound diagnosis of endometriosis and adenomyosis: State of the art. Best Pract Res Clin Obstet Gynaecol., 2018; 51: 16-24.
VANNUCCINI S, et al. Recent advances in understanding and managing adenomyosis. F1000Res., 2019; 8: F1000.
YU O, et al. Adenomyosis incidence, prevalence and treatment: United States population-based study 2006-2015. Am J Obstet Gynecol. 2020; 223(1): 94.e1-94.e10.
ZHAI J, et al. Adenomyosis: Mechanisms and Pathogenesis. Semin Reprod Med., 2020; 38(2-03): 129-143.